Try our beta test site
1 study found for:    lymphoma OR CLL | MEDI-570
Show Display Options
Rank Status Study
1 Recruiting Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma
Conditions: Follicular Variant Peripheral T-Cell Lymphoma;   Recurrent Angioimmunoblastic T-cell Lymphoma;   Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma;   Refractory Angioimmunoblastic T-cell Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Interventions: Biological: Anti-ICOS Monoclonal Antibody MEDI-570;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study

Study has passed its completion date and status has not been verified in more than two years.